Changes

no edit summary
Line 1,478: Line 1,478:  
|
 
|
 
|
 
|
|Lymphoplasmacytic Lymphoma + Waldenstrom Macroglobulinemia
+
|(1) Lymphoplasmacytic Lymphoma + (2) Waldenstrom Macroglobulinemia
|Kapitolina Semenova, MD, Jack Reid, MD, Fabiola Quintero-Rivera, MD  Departments of Pathology, Laboratory Medicine, and *Pediatrics, Division of Genetic and Genomic Medicine, University of California, Irvine (UCI)
+
|(1 and 2) Kapitolina Semenova, MD, Jack Reid, MD, Fabiola Quintero-Rivera, MD  Departments of Pathology, Laboratory Medicine, and Pediatrics, Division of Genetic and Genomic Medicine, University of California, Irvine (UCI)
 
|Complete
 
|Complete
 
|4/12/2023 by FQR
 
|4/12/2023 by FQR
Line 1,576: Line 1,576:  
|
 
|
 
|Author also needs to correlate with 4th edition disease "Testicular Follicular Lymphoma", which is no longer a separate entity
 
|Author also needs to correlate with 4th edition disease "Testicular Follicular Lymphoma", which is no longer a separate entity
|Follicular Lymphoma + Testicular Follicular Lymphoma
+
|(1) Follicular Lymphoma + (2) Testicular Follicular Lymphoma
|Ruthann Pfau, PhD, FACMG, Nationwide Children's Hospital  Rachel D. Burnside, PhD, MBA, FACMG, University of Florida
+
|(1 and 2) Ruthann Pfau, PhD, FACMG, Nationwide Children's Hospital  Rachel D. Burnside, PhD, MBA, FACMG, University of Florida
 
|Pending
 
|Pending
 
|
 
|
Line 1,779: Line 1,779:  
|-
 
|-
 
|[[HAEM5:Primary large B-cell lymphoma of immune-privileged sites|Primary large B-cell lymphoma of immune-privileged sites]]||Disease|| || || || || ||GC|| ||
 
|[[HAEM5:Primary large B-cell lymphoma of immune-privileged sites|Primary large B-cell lymphoma of immune-privileged sites]]||Disease|| || || || || ||GC|| ||
|Diffuse Large B-cell Lymphoma, Not Otherwise Specified + Primary Diffuse Large B-cell Lymphoma of the CNS
+
|(1) Diffuse Large B-cell Lymphoma, Not Otherwise Specified + (2) Primary Diffuse Large B-cell Lymphoma of the CNS
|Ashwini Yenamandra, PhD FACMG, Vanderbilt University Medical Center + Laveniya Satgunaseelan, FRCPA, Department of Neuropathology, Royal Prince Alfred Hospital
+
|(1) Ashwini Yenamandra, PhD FACMG, Vanderbilt University Medical Center + (2) Laveniya Satgunaseelan, FRCPA, Department of Neuropathology, Royal Prince Alfred Hospital
|Pending + Complete
+
|(1) Pending + (2) Complete
|Not ready + 03/28/22
+
|(1) Not ready + (2) 03/28/22
 
|For "Diffuse Large B-cell Lymphoma, Not Otherwise Specified" page from Ash, Greg requested to update 14022022
 
|For "Diffuse Large B-cell Lymphoma, Not Otherwise Specified" page from Ash, Greg requested to update 14022022
 
|-
 
|-
Line 1,894: Line 1,894:  
|-
 
|-
 
|Nodular lymphocyte predominant Hodgkin lymphoma||Disease|| || || || || ||GC|| ||
 
|Nodular lymphocyte predominant Hodgkin lymphoma||Disease|| || || || || ||GC|| ||
|
+
|NEW (No Prior)
|
+
|NEW (No Prior)
|
+
|NEW (No Prior)
|
+
|NEW (No Prior)
|
+
|NEW (No Prior)
 
|-
 
|-
 
|Cold agglutinin disease
 
|Cold agglutinin disease